Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of AN2728 Topical Ointment,
2% and 0.5%, administered once a day (QD) or twice a day (BID), in the treatment of
adolescents with atopic dermatitis (AD)